Atria Investments’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.06M Buy
374,157
+39,703
+12% +$961K 0.09% 231
2026
Q1
$8.11M Buy
334,454
+12,059
+4% +$293K 0.09% 240
2025
Q4
$7.83M Buy
322,395
+117,810
+58% +$2.86M 0.09% 249
2025
Q3
$4.98M Buy
204,585
+4,042
+2% +$98K 0.06% 393
2025
Q2
$4.87M Sell
200,543
-20,670
-9% -$499K 0.06% 391
2025
Q1
$5.35M Buy
221,213
+8,843
+4% +$213K 0.07% 346
2024
Q4
$5.09M Buy
212,370
+91,672
+76% +$2.21M 0.06% 341
2024
Q3
$2.94M Buy
120,698
+9,502
+9% +$229K 0.04% 539
2024
Q2
$2.64M Buy
111,196
+3,418
+3% +$80.8K 0.03% 547
2024
Q1
$2.57M Buy
107,778
+6,417
+6% +$153K 0.04% 559
2023
Q4
$2.43M Buy
+101,361
New +$2.37M 0.04% 528
2023
Q3
– Hold
0
– – – 762

Other funds holding IBDS

Atria Investments's IBDS Position: Q2 2026 in Review

Atria Investments increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 12% in Q2 2026, buying an estimated $961K and bringing the position to 374,157 shares worth $9.06M. The position accounts for 0.09% of the portfolio, ranked #231.

Atria Investments first reported a position in IBDS in Q4 2023 and has held it in 11 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Atria Investments held 374,157 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $9.06M as of Q2 2026.
  • Atria Investments bought 39,703 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $961K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.09% of Atria Investments's portfolio in Q2 2026, its #231 holding.
  • Atria Investments first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.